Recombinant CD70 (Cusatuzumab Biosimilar) antibody (Biotin)

Catalog No. ABIN7829064

The Biotin-conjugated Humanized Monoclonal anti-CD70 (Cusatuzumab Biosimilar) antibody (ABIN7829064) specifically detects CD70 (Cusatuzumab Biosimilar). The antibody is reactive with Human samples.

Quick Overview for Recombinant CD70 (Cusatuzumab Biosimilar) antibody (Biotin) (ABIN7829064)

Target: CD70 (Cusatuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This CD70 (Cusatuzumab Biosimilar) antibody is conjugated to Biotin

Grade: Research Grade

Product Details anti-CD70 (Cusatuzumab Biosimilar) Antibody (Biotin)

Purpose: Biotinylated Anti-CD70(cusatuzumab biosimilar) mAb

Isotype: IgG1

Application Details

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Please see Certificate of Analysis for specific instructions of reconstitution.

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for CD70 (Cusatuzumab Biosimilar)

Target: CD70 (Cusatuzumab Biosimilar)

Alternative Name: Cusatuzumab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:CD27L,LPFS3,CD27-L,CD27LG,TNFSF7,TNLG8A
Synonyms Antibody:ARGX-110,ARGX110,JNJ 74494550,JNJ74494550,JNJ-74494550,JNJ-4550,JNJ4550

UniProt: P32970